Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling

Genes involved in prostate cancer progression determine MRI visibility

(2018) Ping Li et al.   Theranostics

Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target

(2018) Jae Hun Jung et al.   CANCER LETTERS

Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade

(2017) Hui-wen Lue et al.   GENES & DEVELOPMENT

Hypoacetylation of acetyl-histone H3 (H3K9ac) as marker of poor prognosis in oral cancer

(2017) Liana P Webber et al.   HISTOPATHOLOGY

Metabolic changes in patients with prostate cancer during androgen deprivation therapy

(2017) Koji Mitsuzuka et al.   INTERNATIONAL JOURNAL OF UROLOGY

Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection

(2017) Mariette Labots et al.   Journal of Proteomics

Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory

(2017) Philipp Mews et al.   NATURE

Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer

(2017) Fátima Valdés-Mora et al.   Nature Communications

Lipid degradation promotes prostate cancer cell survival

(2017) Harri M. Itkonen et al.   Oncotarget

Glucose Metabolism in the Progression of Prostate Cancer

(2017) Francesca Cutruzzolà et al.   Frontiers in Physiology

An efficient quantitation strategy for hydroxyl radical-mediated protein footprinting using Proteome Discoverer

(2016) Aimee Rinas et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer

(2016) Shih-Chieh Lin et al.   Nature Communications

Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia

(2016) Xue Gao et al.   Nature Communications

Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells

(2016) Bradley Smith et al.   Cell Reports

Diet-induced alteration of fatty acid synthase in prostate cancer progression

(2016) M Huang et al.   Oncogenesis

Acetyl-CoA and the regulation of metabolism: mechanisms and consequences

(2015) Lei Shi et al.   CURRENT OPINION IN CELL BIOLOGY

Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K

(2015) Rupert Courtnay et al.   MOLECULAR BIOLOGY REPORTS

Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis

(2015) Fei Gao et al.   Oncotarget

Regulation of microtubule dynamics by DIAPH3 influences amoeboid tumor cell mechanics and sensitivity to taxanes

(2015) Samantha Morley et al.   Scientific Reports

Predicting Drug Response in Human Prostate Cancer from Preclinical Analysis of In Vivo Mouse Models

(2015) Antonina Mitrofanova et al.   Cell Reports

The role of epithelial plasticity in prostate cancer dissemination and treatment resistance

(2014) Rhonda L. Bitting et al.   CANCER AND METASTASIS REVIEWS

Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy

(2014) Alvaro Aytes et al.   CANCER CELL

Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth

(2014) Yajuan Gao et al.   CANCER LETTERS

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013

(2013) G. Schernthaner et al.   DIABETES CARE

c-Myc and Cancer Metabolism

(2012) D. M. Miller et al.   CLINICAL CANCER RESEARCH

Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression

(2012) J. M. Drake et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Lipids and prostate cancer

(2012) Janel Suburu et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Emerging roles of PKM2 in cell metabolism and cancer progression

(2012) Weibo Luo et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy

(2011) Y. Sun et al.   CANCER RESEARCH

Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells

(2010) Sybille Mazurek   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Targeting anoikis resistance in prostate cancer metastasis

(2010) Shinichi Sakamoto et al.   MOLECULAR ASPECTS OF MEDICINE

HitPredict: a database of quality assessed protein–protein interactions in nine species

(2010) Ashwini Patil et al.   NUCLEIC ACIDS RESEARCH

The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes

(2010) A. J. Levine et al.   SCIENCE

AMP-activated protein kinase promotes human prostate cancer cell growth and survival

(2009) H. U. Park et al.   MOLECULAR CANCER THERAPEUTICS

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth

(2009) T. Hitosugi et al.   Science Signaling

Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer

(2008) K A Landers et al.   BRITISH JOURNAL OF CANCER

Pyruvate kinase M2 is a phosphotyrosine-binding protein

(2008) Heather R. Christofk et al.   NATURE

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

(2008) Heather R. Christofk et al.   NATURE